Facebook
Twitter
LinkedIn
ForwardDescription:
Clinicians require a mechanism to remain up to date with the epidemiology of COVID-19, including newer variants, recent developments regarding treatment, vaccines, and current best practices for long-term COVID-19, which is a debilitating condition of unknown etiology. This series will address the current state of the COVID-19 pandemic, the dominant variants, and treatment options/prevention through vaccines.
Target Audience:
Physicians (MD or DO)
Other Healthcare Professionals
Session Learning Objectives:
After Attending this Activity, Learners Should be Able to:
1.) Cite the current thinking about the pathogenesis of Long COVID-19
2.) Restate the current recommendations about the updated COVID vaccines
3.) Infer how SARS CoV-2 is evolving.
4.) Describe the changing epidemiology of COVID-19.
Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
- Titanji B. K. (2023). The Last Mile Problem-Coronavirus Disease 2019 Vaccine Coverage Among the Most Socially Vulnerable. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 76(9), 1626–1627. https://doi.org/10.1093/cid/ciad006
- Boehmer TK, Koumans EH, Skillen EL, et al. Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 ― United States, January–July 2022. MMWR Morb Mortal Wkly Rep 2022;71:1359–1365. DOI: http://dx.doi.org/10.15585/mmwr.mm7143a2.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.